Is Ed Houben Europe's Most Virile Man?
By BBC,
BBC News
| 03. 19. 2014
In a farm house in north-western Germany, heated by a lively fire in a wood-burning stove, a bulky and bespectacled Dutchman - he freely admits he is a bit on the heavy side - makes his way upstairs to the baby's room.
Ed Houben has come to see his daughter for the first time.
He talks gently to the six-week-old baby, and little Madita looks up at him. She is, he says, his 98th child.
Mr Houben is a "charitable sperm donor". He helps lesbian couples, single women and heterosexual couples with fertility problems to have children free of charge.
He started out in 2002 donating sperm to a sperm bank.
But his sperm donating career (he has a day job, by the way, as a tour guide) really hit its stride when the Netherlands, like many other European countries and Canada, banned anonymous sperm donation and he started offering his services for free on the internet.
'Looking for Ed'
He now donates his sperm in the "traditional way". Using the apparatus God gave him rather than a syringe. "Much...
Related Articles
By Rhys Blakely, The Times | 06.24.2025
Scientists have created fertile mice from male genetic material alone, a breakthrough that could one day open the door to human babies who inherit their genes from two fathers.
The experiment, led by Professor Yanchang Wei at Shanghai Jiao Tong...
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...